Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Novartis Pharmaceuticals
Robert Zeiser; Nikolas von Bubnoff; Jason Butler; Mohamad Mohty; Dietger Niederwieser; Reuven Or; Jeff Szer; Eva M Wagner; Tsila Zuckerman; Bruyère Mahuzier; Judith Xu; Celine Wilke; Kunal K Gandhi; Gérard Socié; REACH2 Trial Group